Biotechnology
INOVIO Announces Initiation of Phase 2 Segment of its Phase 2/3 Clinical Trial for its COVID-19 DNA Vaccine Candidate, INO-4800; Trial Will Be Funded by the U.S. Department of Defense
PLYMOUTH MEETING, Pa., Nov. 16, 2020 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, today announced that it has received clearance from the U.S. Food & Dru...
2020-11-16 20:00
3792
Cytiva supports Clover Biopharmaceuticals to scale up the output of its vaccine candidate
* Clover aims to double its commercial manufacturing capacity in preparation for global Phase 2/3 trials * Cytiva provides FlexFactory™ bioprocessing upstream and downstream solutions for Clover to accelerate GMP facility development and shorten time to market SHANGHAI, Nov. 16, 2020 /PRNewsw...
2020-11-16 14:00
1582
Innovent Announces the Results of the Phase I Clinical Trial of IBI302, a First-in-class Ophthalmic Recombinant Human Anti-VEGF and Anti-Complement Bi-specific Fusion Protein for Neovascular Age-Related Macular Degeneration at 2020 American Academy of Ophthalmology
SAN FRANCISCO and SUZHOU, China, Nov. 16, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other major di...
2020-11-16 08:00
5629
The third CIIE concludes, $72.6 billion in intended deals for the coming year inked
SHANGHAI, Nov. 14, 2020 /PRNewswire/ -- Despite the global market uncertainties caused by the COVID-19 pandemic, the confidence and interest that foreign companies have in the Chinese market appear unchanged, with the value of tentative deals reached for one-year purchases of goods and services a...
2020-11-14 03:21
5527
Positive Results from RhoVac's Clinical Phase I/II Study published in Journal of ImmunoTherapy of Cancer
STOCKHOLM, Nov. 13, 2020 /PRNewswire/ -- RhoVac announces today, November 13, 2020, that the results of its clinical phase I/II study have been published in the Journal for ImmunoTherapy of Cancer (JITC). The scientifically reviewed article reports that the treatment with RhoVac's drug candidate ...
2020-11-13 17:53
2316
Molecular Stethoscope Announces Completion of its NAFLD/NASH Study and Podium Presentation of Results by Dr. Naga Chalasani at the AASLD Liver Meeting 2020
Study results demonstrate the utility of the company's Next-Generation cf-mRNA Liquid Biopsy-Artificial Intelligence Technology Platform for the characterization of NAFLD/NASH disease PALO ALTO, Calif., Nov. 13, 2020 /PRNewswire/ -- Molecular Stethoscope, Inc., a precision medicine biotechnology...
2020-11-13 04:19
1998
XJTLU launches new Academy of Pharmacy
SUZHOU, China, Nov. 12, 2020 /PRNewswire/ -- On 11 November 2020, Xi'an Jiaotong-Liverpool University launched its new XJTLU Wisdom Lake Academy of Pharmacy. "The biopharmaceutical industry is one of the fastest-growing sectors worldwide," says DrYimin Ding, Vice President of XJTLU. "It is als...
2020-11-12 15:13
2107
CStone Pharmaceuticals Announces China's NMPA has Accepted its New Drug Application for anti-PD-L1 Monoclonal Antibody Sugemalimab in First-Line Advanced NSCLC
* Currently, there is no anti-PD-L1 monoclonal antibody approved for stage IV NSCLC inChina * An oral presentation of specific clinical trial data of CS1001-302 study will be given at ESMO Asia Congress onNovember 21st SUZHOU, China, Nov. 12, 2020 /PRNewswire/ -- CStone Pharmaceuticals ("CSto...
2020-11-12 10:58
4603
Suh Kyungbae Science Foundation holds the first symposium
* Sharing the outcome of the research work of five young scientists selected in 2017 * Awarding certificates to three young scientists of 2020 SEOUL, South Korea, Nov. 12, 2020 /PRNewswire/ -- Suh Kyungbae Science Foundation (Chairman Suh Kyungbae) held the SUHF Symposium 2020 at Amore Hall, ...
2020-11-12 08:00
2312
Innovation Drives Excellence, Innovent Successfully Held 2020 Virtual R&D Day
SAN FRANCISCO and SUZHOU, China, Nov. 11, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for treatment of oncology, metabolic, autoimmune and other major diseas...
2020-11-11 08:00
8199
FibroGenesis Announces the Filing of its 250th Patent for Fibroblast Cell Therapy Platform
World Leader in Fibroblast Technology Advances Intellectual Property Position with their 250th Patent Filed Today HOUSTON, Nov. 10, 2020 /PRNewswire/ -- FibroGenesis, a Texas-based regenerative medicine company focused on tissue regeneration and chronic disease reversal using Human Dermal Fibrob...
2020-11-10 22:37
1651
Semaglutide 2.4 mg injection demonstrated significant weight loss versus placebo when added to intensive behavioural therapy
BAGSVÆRD, Denmark, Nov. 6, 2020 /PRNewswire/ -- Results of a phase 3a trial showed that investigational drug semaglutide 2.4 mg once-weekly subcutaneous as an adjunct to intensive behavioural therapy (IBT) demonstrated significantly more body weight loss compared to placebo plus IBT.[i] The STEP ...
2020-11-06 01:50
2494
Cellarity signs up with Excelra for GOSTAR database to enrich its drug discovery platform
HYDERABAD, India and CAMBRIDGE, Mass., Nov. 5, 2020 /PRNewswire/ -- Excelra
2020-11-05 10:00
3098
Nel ASA: Selected by Iberdrola as preferred supplier for a 20 MW green fertilizer project in Spain
OSLO, Norway, Nov. 4, 2020 /PRNewswire/ -- Nel Hydrogen Electrolyser, a division of Nel ASA (Nel, OSE:NEL), has been selected as preferred supplier by Iberdrola for a 20 MW PEM solution for a green fertilizer project inSpain. Contract award is subject to mutual agreement on the final commercial t...
2020-11-04 03:35
11189
RevImmune advances new immunotherapy in COVID-19
BETHESDA, Md., Nov. 2, 2020 /PRNewswire/ -- RevImmune, a privately held biotech company based inParis, France and Bethesda, MD, developing CYT107 (recombinant human Interleukin-7) for infectious diseases, sepsis and cancer, announced today that its "ILIAD-7" international randomized controlled Ph...
2020-11-02 21:00
2641
MBS LABTECH officially launched to sell MBS Capillary Tube designed for biochemistry, immunology, and blood tests in Singapore
SINGAPORE, Nov. 2, 2020 /PRNewswire/ -- MBS LABTECH is delighted to announce the official launch of our website, offering ready access to the MBS Capillary Tube inSingapore and regional markets. The MBS Capillary Tube is designed for simple and precise fingertip blood collection to be used for bi...
2020-11-02 10:00
2019
Investments aim to strengthen capabilities of DuPont(TM) Liveo(TM) healthcare silicone solutions
WILMINGTON, Del., Nov. 2, 2020 /PRNewswire/ -- DuPont™ (NYSE: DD), a globally recognized leader in silicone-based technology and innovations for healthcare, is making significant investments in both capital and resources to strengthen strategic capabilities of its Liveo™ brand healthcare silicone...
2020-11-02 09:00
1917
AVATAMED and Macrogen sign MOU on joint business in personalized precision medicine services in cancer treatment
SINGAPORE, Oct. 30, 2020 /PRNewswire/ -- AVATAMED (www.avatamed.com
2020-10-30 08:00
2842
AGC Biologics and Horizon Therapeutics plc Expand Partnership
Horizon's TEPEZZA® (teprotumumab-trbw) treatment will be produced from AGC Biologics' new facility inBoulder, CO SEATTLE, Oct. 30, 2020 /PRNewswire/ -- AGC Biologics, a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced that its partnership wit...
2020-10-30 03:17
5028
ZAGENO Acclaimed by Frost & Sullivan for Simplifying the Biotech Purchasing Process with Its Intuitive eCommerce Platform
The platform serves researchers' unique experimental needs by presenting them with the industry's broadest solution portfolio of millions of product SKUs LONDON, Oct. 29, 2020 /PRNewswire/ -- Based on its recent analysis of the global life sciences eCommerce market, Frost & Sullivan recognizesZAG...
2020-10-29 21:00
2184
Week's Top Stories
Most Reposted
Going Global: DCITS Embarks on International Expansion at Singapore Fintech Festival
[Picked up by 313 media titles]
2024-11-12 09:00
DKSH Healthcare and Euris Unveil CRM & MCE Platform "ConnectPlus" to Revolutionize APAC Healthcare Distribution
[Picked up by 293 media titles]
2024-11-13 09:00
Sobot Introduces its All-in-One Solution at GITEX Global 2024
[Picked up by 291 media titles]
2024-11-12 11:00
Ubiqconn Technology to Showcase Latest Marine Solutions at the 2024 International WorkBoat Show in New Orleans
[Picked up by 289 media titles]
2024-11-11 21:00
Transformation of Asia's Process Industries To Get A Boost Through Region's First Dedicated Process Technology Show
[Picked up by 279 media titles]
2024-11-12 16:00
Most Read
Sobot Introduces its All-in-One Solution at GITEX Global 2024
2024-11-12 11:00
5754
Going Global: DCITS Embarks on International Expansion at Singapore Fintech Festival
2024-11-12 09:00
5654
